We’re excited to announce that Axent Bio has been awarded a Translational Award from the California Institute for Regenerative Medicine (CIRM) to advance our scalable cell therapy platform for Parkinson’s disease.
This award is part of CIRM’s ongoing commitment to accelerate innovative regenerative medicine programs with strong clinical potential. We’re honored to be among the select group of recipients and look forward to using this support to drive our platform toward therapeutic application.
Stay tuned as we continue to share progress on this important work.
